Article Details

Aramis Biotechnologies secures $80 million CAD for vaccine development do-over | BetaKit

Retrieved on: 2024-12-07 10:14:48

Tags for this article:

Click the tags to see associated articles and topics

Aramis Biotechnologies secures $80 million CAD for vaccine development do-over | BetaKit. View article details on hiswai:

Excerpt

Medicago was awarded over $300 million from the federal government in 2020 to build a vaccine manufacturing plant in Québec and deliver COVID-19 shots ...

Article found on: betakit.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo